ATIP vs. ENZ, BRTX, MGRX, SSY, OTRK, BGLC, ACON, DHAC, VSEE, and NIVF
Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include Enzo Biochem (ENZ), Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Ontrak (OTRK), BioNexus Gene Lab (BGLC), Aclarion (ACON), Digital Health Acquisition (DHAC), Vsee Health (VSEE), and NewGenIvf Group (NIVF). These companies are all part of the "healthcare" industry.
ATI Physical Therapy vs. Its Competitors
ATI Physical Therapy (NYSE:ATIP) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.
72.6% of ATI Physical Therapy shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 3.3% of ATI Physical Therapy shares are owned by insiders. Comparatively, 11.4% of Enzo Biochem shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Enzo Biochem has lower revenue, but higher earnings than ATI Physical Therapy.
In the previous week, Enzo Biochem had 3 more articles in the media than ATI Physical Therapy. MarketBeat recorded 3 mentions for Enzo Biochem and 0 mentions for ATI Physical Therapy. Enzo Biochem's average media sentiment score of 0.40 beat ATI Physical Therapy's score of 0.00 indicating that Enzo Biochem is being referred to more favorably in the news media.
Enzo Biochem received 197 more outperform votes than ATI Physical Therapy when rated by MarketBeat users. Likewise, 52.22% of users gave Enzo Biochem an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.
ATI Physical Therapy has a net margin of -7.79% compared to Enzo Biochem's net margin of -75.34%. ATI Physical Therapy's return on equity of 0.00% beat Enzo Biochem's return on equity.
ATI Physical Therapy has a beta of -0.17, indicating that its stock price is 117% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.
Summary
Enzo Biochem beats ATI Physical Therapy on 8 of the 13 factors compared between the two stocks.
Get ATI Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ATI Physical Therapy Competitors List
Related Companies and Tools
This page (NYSE:ATIP) was last updated on 6/22/2025 by MarketBeat.com Staff
